Ask AI
ProCE Banner Series

The Next Chapter in CSU: Expert Dialogues in Diagnosis and Leveraging New and Emerging Therapies

Join leading experts for a dynamic roundtable discussion exploring the evolving landscape of chronic spontaneous urticaria (CSU). This program will review key cellular and molecular mechanisms underlying CSU, highlight the disease burden, and discuss evidence-based approaches to diagnosis and assessment. Faculty will also examine recent clinical data on available and emerging therapies and provide practical insights to help HCPs optimize treatment strategies for patients with CSU.

  AAPA
  | AMA
  | ANCC
Who Should Attend

This activity is intended for allergy/immunology and dermatology healthcare professionals, including physicians, residents, fellows, nurse practitioners, and physician associates, and others who care for patients with CSU.

All Events

The Next Chapter in CSU: Expert Dialogues in Diagnosis and Leveraging New and Emerging Therapies

Upcoming Events

April

22

2026

3:00 PM - 4:00 PM Eastern Time (ET)

Virtual

Topics

Supportive Care

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of allergy/immunology and dermatology healthcare professionals to promote timely diagnosis, disease control, and quality of life for patients with CSU.

Target Audience
This activity is intended for allergy/immunology and dermatology healthcare professionals, including physicians, residents, fellows, nurse practitioners, and physician associates, and others who care for patients with CSU.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify key cellular and molecular mechanisms involved in the pathophysiology of CSU

  • Characterize factors contributing to the burden of living with CSU

  • Design evidence-based diagnostic and assessment plans for all patients with CSU

  • Evaluate recent clinical data on available and emerging therapies for patients with CSU

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191